|
RBM19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42519999638091E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70099999996509E-06 |
| Normal-vs-Stage2 |
2.175900E-03 |
| Normal-vs-Stage3 |
1.173090E-04 |
| Normal-vs-Stage4 |
2.041700E-03 |
| Stage1-vs-Stage2 |
8.686200E-01 |
| Stage1-vs-Stage3 |
7.170400E-01 |
| Stage1-vs-Stage4 |
7.738200E-01 |
| Stage2-vs-Stage3 |
6.476200E-01 |
| Stage2-vs-Stage4 |
6.925600E-01 |
| Stage3-vs-Stage4 |
9.531600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59079999676004E-08 |
| Normal-vs-AfricanAmerican |
1.57826999999111E-05 |
| Normal-vs-Asian |
1.162230E-01 |
| Caucasian-vs-AfricanAmerican |
5.723400E-01 |
| Caucasian-vs-Asian |
3.576000E-01 |
| AfricanAmerican-vs-Asian |
4.264600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.00350000215622E-08 |
| Normal-vs-Female |
4.86750000305847E-08 |
| Male-vs-Female |
5.160000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.433100E-04 |
| Normal-vs-Extreme_Weight |
2.46749999999185E-05 |
| Normal-vs-Obese |
3.44050000045115E-07 |
| Normal-vs-Extreme_Obese |
3.379900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.942000E-01 |
| Normal_Weight-vs-Obese |
3.030000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.010200E-01 |
| Extreme_Weight-vs-Obese |
5.435000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.907400E-01 |
| Obese-vs-Extreme_Obese |
2.097400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.98539999995972E-08 |
| Normal-vs-Age(41-60Yrs) |
9.08260000542782E-09 |
| Normal-vs-Age(61-80Yrs) |
9.35500000021072E-07 |
| Normal-vs-Age(81-100Yrs) |
1.222220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.782300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.437400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.020000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.354600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.569700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.076000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.49669998616986E-09 |
| Normal-VS-Type2 PRCC |
4.343700E-03 |
| Normal-VS-KIRP CIMP |
1.317440E-03 |
| Normal-VS-Unclassified PRCC |
9.00750000032424E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.433200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.900200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.936600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.842600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.320860E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.297800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.743200E-03 |
| Normal-vs-N1 |
1.58660000004751E-06 |
| Normal-vs-N2 |
9.556700E-04 |
| N0-vs-N1 |
1.077730E-02 |
| N0-vs-N2 |
1.031040E-01 |
| N1-vs-N2 |
7.288800E-01 |
|
|
